Transgenomic said this week that Paul Kinnon has been named president, CEO, and a director of the company, replacing Craig Tuttle.
Kinnon joins Transgenomic from New Zealand-based ZyGem, where he served as president and CEO. Kinnon joined ZyGem in 2007 from Invitrogen, now part of Life Technologies, where he held the positions of vice president of global strategic alliances and vice president and general manager of the applied markets business unit. Prior to that, Kinnon held business, sales, and marketing roles at Guava Technologies (now part of Millipore), Cellomics (now part of Thermo Fisher Scientific), and other life science companies.
Tuttle served as president and CEO of Transgenomic since July 2006. He was previously the president and COO of Duke Scientific, a specialty particle technology company, and before that he was the president and CEO of Applied Biotech, a point-of-care rapid diagnostics manufacturer in the Apogent Technologies group.